 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Shield Therapeutics Plc is a commercial stage specialty pharmaceutical company, which engages in addressing iron deficiency with its lead product Accrufer. It operates the Feraccru and PT20 segments. The Feraccru segment refers to the development and commercialization of this product. The PT20 segment related to the development of its secondary asset. The company was founded by Carl Sterritt and Christian Schweiger in 2008 and is headquartered in Gateshead Quays, the United Kingdom.

Watchers	24
52-Wk Low	$0.072
52-Wk High	$0.151

Market Cap	$47.31M
Volume (M)	200.00
52-Wk High	$0.151
52-Wk Low	$0.072

Current Price	$0.072
Prev Close	$0.074
Open	$0.072
Dividend Yield	0.00%
50-Day Moving Average	$0.0864
Beta	0.16
Avg. Volume	9.52
PE Ratio	-0.46

52-Week High	$0.151
52-Week Low	$0.072
Market Capitalization	$47.31M
EPS	-$0.1575
Price to Book	1.89
Revenue Per Employee	$266,465.73
Enterprise Value/EBITDA	-1.69

SHIEF Shield Therapeutics PLC

About

Feed

News

Fundamentals